Josh Gottheimer
Josh Gottheimer (D-NJ) bought $1K-$15K of $ABBV (AbbVie Inc. Common Stock) on May 22, 2025, part of 24 transactions in this filing (16 buys, 8 sells).
HillSignal flagged 4 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
4 flagsRep. Gottheimer bought $1,001 - $15,000 in $MSFT on 2025-05-21 — 1 day before the "Access Technology Affordability Act of 2025" (S1918) was introduced, which could offer tax credits for technology purchases.
Rep. Gottheimer bought $1,001 - $15,000 in $MSFT on 2025-05-21 and 2025-05-22 — 21 and 22 days before the "CREATE JOBS Act" (S2056) was introduced, proposing permanent 100% bonus depreciation.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $ABBV | AbbVie Inc. Common Stock | $1K-$15K | $182.54 | — | — | May 22, 2025 |
| BUY | $APP | Applovin Corporation - Class A Common Stock | $1K-$15K | $390.26 | — | — | May 28, 2025 |
| BUY | $ASML | ASML Holding N.V. - New York Registry Shares | $1K-$15K | $740.70 | — | — | May 22, 2025 |
| BUY | $GLW | Corning Incorporated Common Stock | $1K-$15K | $49.45 | — | — | May 28, 2025 |
| BUY | $GLW | Corning Incorporated Common Stock | $1K-$15K | $49.45 | — | — | May 22, 2025 |
| BUY | $LLY | Eli Lilly and Company Common Stock | $1K-$15K | — | — | — | May 1, 2025 |
| BUY | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | $452.57 | — | — | May 21, 2025 |
| BUY | $MSFT | Microsoft Corporation - Common Stock | $1K-$15K | $452.57 | — | — | May 22, 2025 |
| BUY | $CRM | Salesforce, Inc. Common Stock | $1K-$15K | $283.42 | — | — | May 22, 2025 |
| BUY | $SE | Sea Limited American Depositary Shares, each representing one Class A Ordinary Share | $1K-$15K | $164.06 | — | — | May 23, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Treat and Reduce Obesity Act of 2025
The Treat and Reduce Obesity Act of 2025 would mandate Medicare Part D coverage of GLP-1 obesity drugs, unlocking a massive new payer market of ~27 million beneficiaries. $NVO and $LLY are the two direct beneficiaries. The bill is in early-stage committee referral with 22 bipartisan cosponsors; no companion bill has passed the House yet. Real market data shows $NVO gaining 15.56% over 30 days vs $LLY's +0.7%, suggesting the market may be overweighting Novo's near-term Medicare exposure given its larger U.S. obesity market share.
Taiwan Non-Discrimination Act of 2025
HR910 is a diplomatic bill requiring the U.S. Treasury to advocate for Taiwan's equitable treatment at the IMF. It authorizes zero funding, imposes no mandatory regulations on U.S. companies, and has no direct market impact on any publicly traded entity. The bill is procedural in nature—directing U.S. votes within an international institution—and carries no binding economic mechanisms for U.S. firms.
DeOndra Dixon INCLUDE Project Act of 2025
HR3491 (DeOndra Dixon INCLUDE Project Act) authorizes a Down syndrome research program at NIH but appropriates zero funding. With only 5 procedural actions over a year and stalled committee markup, the bill has no near-term market impact. No public companies are directly affected.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.
Small Biotech Innovation Act
The Small Biotech Innovation Act (HR3731) is an early-stage bill that would exempt R&D-intensive small biotech manufacturers (≤5 qualifying drugs) from Medicare drug price negotiations starting in 2029. The bill is in committee with no floor action, and no market reaction is evident from provided data. The legislative path is long and uncertain — this is a structural watch item, not a trading catalyst.
Strengthening Agency Management and Oversight of Software Assets Act
S.1956 is an early-stage, unfunded mandate requiring federal agencies to assess their software assets. It creates a bounded, short-term consulting opportunity for IT services firms like ACN and CDW, but the lack of new appropriations limits the financial impact. Real market data confirms the bill has zero pricing signal — ACN, IBM, ORCL, and MSFT moved on broader tech rotation, not this legislation.
Access Technology Affordability Act of 2025
S. 1918 is an early-stage, low-probability bill proposing a refundable tax credit for blind individuals purchasing access technology. It creates no direct revenue stream for any public company and has negligible near-term market impact.
STOP CSAM Act of 2025
The STOP CSAM Act (S.1829) has advanced to the Senate calendar, increasing passage probability. The bill mandates elevated content moderation and reporting requirements for major tech and telecom companies, directly increasing compliance costs. Affected tickers include $META, $GOOGL, $MSFT, $AMZN, $VZ, $T, and $TWLO. Market data shows strong recent rallies in tech stocks ($GOOGL +27.95%, $META +24.75%, $AMZN +30.9% over 30 days), creating potential downside risk if compliance cost headwinds materialize.
Streamlining Federal Cybersecurity Regulations Act of 2025
S.1875 is an early-stage procedural bill to create an interagency committee for harmonizing federal cybersecurity regulations. It contains no funding, no mandates, and no procurement directives. Near-term market impact is negligible.
IGNITEACTION LLC: $16.1M Department of Commerce Contract
This $16.1 million contract to IGNITEACTION LLC for cloud infrastructure support at the U.S. Census Bureau represents a steady demand for IT modernization services, likely benefiting major cloud providers and IT consulting firms. While IGNITEACTION is private, this award signals continued federal investment in cloud migration, a positive trend for the broader technology sector.
Other Filings by Josh Gottheimer
Free — no credit card
Get the next Gottheimer trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.